RxDoctor Payments Data

Brandy McDonald

Psychiatric/Mental Health · Columbia, MONPI 1871166843

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 320 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,351, more than ten times the $197 reported in 2021. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,836in general payments, 2019–2025

Across 320 payments — averaging $24.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • Johnson & Johnson$1K
  • Otsuka America Pharmaceutical, Inc.$890
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$858
  • Neurocrine Biosciences, Inc.$839
  • Axsome Therapeutics, Inc.$722
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$7,71298%
  • Education$1242%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,836 in reported general payments places this provider in the 90th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$4,322
Medicare patients
19
Services billed
69

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxyzine Hcl12$134

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →